Crawford expected stay on as permanent FDA commissioner

The White House appears to have selected FDA acting commissioner Lester Crawford as its choice to fill the position on a permanent basis, The Pink Sheet reported this week.
News of the selection came after Crawford reportedly met with President Bush on Jan. 27 – a move considered by Beltway insiders as an indication that a decision has been made and an announcement could come at any time.
Crawford has been acting commissioner since Mark McClellan left the FDA to take the over the Centers for Medicare & Medicaid Services in March.
If Crawford is the nominee, he would become the first to move up from the acting role to fully confirmed position.
You must be a registered member of MMM to post a comment.

Email Newsletters


As US pharma continued its quest for a Grand Prix at the Lions Health international festival of creativity, MM&M went on location to Cannes, France. Missed our coverage from June? Now, we're giving you an opportunity to catch up on some of what you missed. Download our e-book on the two-day festival, recapping the event, rounding up the best of the speakers, offering perspective and listing all of the winners. Click here to download.


The most recent MM&M Skill Sets Live event surveyed a range of issues relating to one of the hottest promotional spaces in healthcare. Speakers and panelists at the morning-long session, including promotional- and multichannel-minded executives from GSK, Epocrates, Treato and Montefiore Medical Center, weighed in on topics designed to help marketers demystify the challenges associated with non-personal promotion. Click here.